Xylazine toxicity: Difference between revisions

No edit summary
Line 6: Line 6:
==Clinical Features==
==Clinical Features==
*[[Bradycardia]]
*[[Bradycardia]]
*[[Respiratory depression]]
*Respiratory depression
*[[Hypotension]]
*[[Hypotension]]



Revision as of 19:46, 21 August 2019

Background

Clinical Features

Differential Diagnosis

Sedative/hypnotic toxicity

Evaluation

  • Evaluate for alternate etiologies
  • Clinical diagnosis

Management

  • Supportive: address airway/respiratory drive/blood pressure, atropine for bradycardia

Disposition

  • Admit if not back to baseline

See Also

External Links

References

https://www.ncbi.nlm.nih.gov/pubmed/24769343